ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Monoclonal Antibody Discovery Platform Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-24S16118
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Monoclonal Antibody Discovery Platform Market Research Report 2024
BUY CHAPTERS

Global Monoclonal Antibody Discovery Platform Market Research Report 2025

Code: QYRE-Auto-24S16118
Report
May 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sartorius
BIOCYTOGEN
Abveris
Integral Molecular
Shanghai Fosun Pharmaceutical Group
Wuxi Biologics
Lepu Biopharma
Harbour Biomed
3SBio Group
SAFE Pharmaceutical Technology
Trianni (AbCellera)
GigaGen
AvantBunny
MAB Discovery (BioNTech)

Monoclonal Antibody Discovery Platform Market

The global market for Monoclonal Antibody Discovery Platform was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Monoclonal antibodies are antibodies secreted by a single B lymphocyte clone. Since B lymphocytes can only produce a proprietary antibody against one antigenic determinant, they have highly specific physical and chemical properties, single biological activity, and Antigen binding specificity and other characteristics. After more than 30 years of research and development, monoclonal antibody drugs have made great progress in the treatment of tumors and autoimmune diseases. They are also the fastest growing and most promising development direction in the pharmaceutical field. This report studies the monoclonal antibody drug discovery platform market.
North American market for Monoclonal Antibody Discovery Platform is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Monoclonal Antibody Discovery Platform is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Monoclonal Antibody Discovery Platform in Biomedical Research is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Monoclonal Antibody Discovery Platform include Sartorius, Trianni (AbCellera), Biocytogen, Abveris, Creative Biolabs, Integral Molecular, GigaGen, Creative Biolabs, AvantBunny, MAB Discovery (BioNTech), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Monoclonal Antibody Discovery Platform, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monoclonal Antibody Discovery Platform.
The Monoclonal Antibody Discovery Platform market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Monoclonal Antibody Discovery Platform market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Monoclonal Antibody Discovery Platform companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Monoclonal Antibody Discovery Platform Market Report

Report Metric Details
Report Name Monoclonal Antibody Discovery Platform Market
Segment by Type
Segment by Application
  • Biomedical Research
  • Disease Diagnosis and Treatment
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sartorius, Trianni (AbCellera), Biocytogen, Abveris, Creative Biolabs, Integral Molecular, GigaGen, AvantBunny, MAB Discovery (BioNTech), Shanghai Fosun Pharmaceutical (Group), WuXi Biologics, Lepu Biopharma, Harbour BioMed, 3SBio Group, SAFE Pharmaceutical Technology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Monoclonal Antibody Discovery Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

What is the scope of the Global Monoclonal Antibody Discovery Platform Market Research Report 2025?

Ans: The Global Monoclonal Antibody Discovery Platform Market Research Report 2025 provides a comprehensive analysis of market trends, drivers, challenges, and opportunities. The report includes a breakdown of the market size by type, application, and region, offering detailed insights into the market's current state and future prospects.

How is the market size segmented in the Global Monoclonal Antibody Discovery Platform Market Research Report 2025?

Ans: The market size in the report is segmented by both type and application. For types, the report includes the following categories: Type 1, Type 2, and Type 3. For applications, the market is broken down by Application 1, Application 2, and Application 3. Each segment provides a detailed statistical analysis of its respective market size.

Does the report provide regional breakdowns of the monoclonal antibody discovery platform market?

Ans: Yes, the report offers a regional breakdown of the monoclonal antibody discovery platform market. This includes detailed market size and forecast data for key regions, allowing for a thorough understanding of geographical trends and growth opportunities.

Are Type and Application breakdowns separate reports?

Ans: No, the breakdowns by type and application are not separate reports. They are included as part of the comprehensive analysis within the Global Monoclonal Antibody Discovery Platform Market Research Report 2025, providing detailed insights into each segment within the same report.

Antibody-Based Markets

Drug Discovery Platforms

Antibody Drug Conjugates

Disclaimer: The following trends serve as an illustrative preview based on secondary sources. Your purchased report is developed through a robust blend of primary and secondary research for validation and depth; specific findings may be prioritized, refined, or expanded in the final report. If anything is unclear, our sales team will be happy to clarify your doubts.
Topic Trends
Global the monoclonal antibody discovery platform market is experiencing growth driven by advancements in drug development for tumors and autoimmune diseases, with increasing adoption of innovative discovery technologies and expansion into emerging markets.

Recommended Reports

Antibody Discovery Platforms

Monoclonal Antibodies Markets

Antibody Drug Conjugates

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monoclonal Antibody Discovery Platform Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 FACS (Fluorescent Activated Cell Sorting)
1.2.3 LCM (Laser-Capture Microdissection)
1.2.4 Microengraving
1.2.5 Droplet Microfluidics
1.2.6 Other
1.3 Market by Application
1.3.1 Global Monoclonal Antibody Discovery Platform Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biomedical Research
1.3.3 Disease Diagnosis and Treatment
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Monoclonal Antibody Discovery Platform Market Perspective (2020-2031)
2.2 Global Monoclonal Antibody Discovery Platform Growth Trends by Region
2.2.1 Global Monoclonal Antibody Discovery Platform Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Monoclonal Antibody Discovery Platform Historic Market Size by Region (2020-2025)
2.2.3 Monoclonal Antibody Discovery Platform Forecasted Market Size by Region (2026-2031)
2.3 Monoclonal Antibody Discovery Platform Market Dynamics
2.3.1 Monoclonal Antibody Discovery Platform Industry Trends
2.3.2 Monoclonal Antibody Discovery Platform Market Drivers
2.3.3 Monoclonal Antibody Discovery Platform Market Challenges
2.3.4 Monoclonal Antibody Discovery Platform Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Monoclonal Antibody Discovery Platform Players by Revenue
3.1.1 Global Top Monoclonal Antibody Discovery Platform Players by Revenue (2020-2025)
3.1.2 Global Monoclonal Antibody Discovery Platform Revenue Market Share by Players (2020-2025)
3.2 Global Monoclonal Antibody Discovery Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Monoclonal Antibody Discovery Platform Revenue
3.4 Global Monoclonal Antibody Discovery Platform Market Concentration Ratio
3.4.1 Global Monoclonal Antibody Discovery Platform Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monoclonal Antibody Discovery Platform Revenue in 2024
3.5 Global Key Players of Monoclonal Antibody Discovery Platform Head office and Area Served
3.6 Global Key Players of Monoclonal Antibody Discovery Platform, Product and Application
3.7 Global Key Players of Monoclonal Antibody Discovery Platform, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Monoclonal Antibody Discovery Platform Breakdown Data by Type
4.1 Global Monoclonal Antibody Discovery Platform Historic Market Size by Type (2020-2025)
4.2 Global Monoclonal Antibody Discovery Platform Forecasted Market Size by Type (2026-2031)
5 Monoclonal Antibody Discovery Platform Breakdown Data by Application
5.1 Global Monoclonal Antibody Discovery Platform Historic Market Size by Application (2020-2025)
5.2 Global Monoclonal Antibody Discovery Platform Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Monoclonal Antibody Discovery Platform Market Size (2020-2031)
6.2 North America Monoclonal Antibody Discovery Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Monoclonal Antibody Discovery Platform Market Size by Country (2020-2025)
6.4 North America Monoclonal Antibody Discovery Platform Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Monoclonal Antibody Discovery Platform Market Size (2020-2031)
7.2 Europe Monoclonal Antibody Discovery Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Monoclonal Antibody Discovery Platform Market Size by Country (2020-2025)
7.4 Europe Monoclonal Antibody Discovery Platform Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Monoclonal Antibody Discovery Platform Market Size (2020-2031)
8.2 Asia-Pacific Monoclonal Antibody Discovery Platform Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Monoclonal Antibody Discovery Platform Market Size by Region (2020-2025)
8.4 Asia-Pacific Monoclonal Antibody Discovery Platform Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Monoclonal Antibody Discovery Platform Market Size (2020-2031)
9.2 Latin America Monoclonal Antibody Discovery Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Monoclonal Antibody Discovery Platform Market Size by Country (2020-2025)
9.4 Latin America Monoclonal Antibody Discovery Platform Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Monoclonal Antibody Discovery Platform Market Size (2020-2031)
10.2 Middle East & Africa Monoclonal Antibody Discovery Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Monoclonal Antibody Discovery Platform Market Size by Country (2020-2025)
10.4 Middle East & Africa Monoclonal Antibody Discovery Platform Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sartorius
11.1.1 Sartorius Company Details
11.1.2 Sartorius Business Overview
11.1.3 Sartorius Monoclonal Antibody Discovery Platform Introduction
11.1.4 Sartorius Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025)
11.1.5 Sartorius Recent Development
11.2 Trianni (AbCellera)
11.2.1 Trianni (AbCellera) Company Details
11.2.2 Trianni (AbCellera) Business Overview
11.2.3 Trianni (AbCellera) Monoclonal Antibody Discovery Platform Introduction
11.2.4 Trianni (AbCellera) Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025)
11.2.5 Trianni (AbCellera) Recent Development
11.3 Biocytogen
11.3.1 Biocytogen Company Details
11.3.2 Biocytogen Business Overview
11.3.3 Biocytogen Monoclonal Antibody Discovery Platform Introduction
11.3.4 Biocytogen Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025)
11.3.5 Biocytogen Recent Development
11.4 Abveris
11.4.1 Abveris Company Details
11.4.2 Abveris Business Overview
11.4.3 Abveris Monoclonal Antibody Discovery Platform Introduction
11.4.4 Abveris Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025)
11.4.5 Abveris Recent Development
11.5 Creative Biolabs
11.5.1 Creative Biolabs Company Details
11.5.2 Creative Biolabs Business Overview
11.5.3 Creative Biolabs Monoclonal Antibody Discovery Platform Introduction
11.5.4 Creative Biolabs Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025)
11.5.5 Creative Biolabs Recent Development
11.6 Integral Molecular
11.6.1 Integral Molecular Company Details
11.6.2 Integral Molecular Business Overview
11.6.3 Integral Molecular Monoclonal Antibody Discovery Platform Introduction
11.6.4 Integral Molecular Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025)
11.6.5 Integral Molecular Recent Development
11.7 GigaGen
11.7.1 GigaGen Company Details
11.7.2 GigaGen Business Overview
11.7.3 GigaGen Monoclonal Antibody Discovery Platform Introduction
11.7.4 GigaGen Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025)
11.7.5 GigaGen Recent Development
11.8 Creative Biolabs
11.8.1 Creative Biolabs Company Details
11.8.2 Creative Biolabs Business Overview
11.8.3 Creative Biolabs Monoclonal Antibody Discovery Platform Introduction
11.8.4 Creative Biolabs Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025)
11.8.5 Creative Biolabs Recent Development
11.9 AvantBunny
11.9.1 AvantBunny Company Details
11.9.2 AvantBunny Business Overview
11.9.3 AvantBunny Monoclonal Antibody Discovery Platform Introduction
11.9.4 AvantBunny Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025)
11.9.5 AvantBunny Recent Development
11.10 MAB Discovery (BioNTech)
11.10.1 MAB Discovery (BioNTech) Company Details
11.10.2 MAB Discovery (BioNTech) Business Overview
11.10.3 MAB Discovery (BioNTech) Monoclonal Antibody Discovery Platform Introduction
11.10.4 MAB Discovery (BioNTech) Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025)
11.10.5 MAB Discovery (BioNTech) Recent Development
11.11 Shanghai Fosun Pharmaceutical (Group)
11.11.1 Shanghai Fosun Pharmaceutical (Group) Company Details
11.11.2 Shanghai Fosun Pharmaceutical (Group) Business Overview
11.11.3 Shanghai Fosun Pharmaceutical (Group) Monoclonal Antibody Discovery Platform Introduction
11.11.4 Shanghai Fosun Pharmaceutical (Group) Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025)
11.11.5 Shanghai Fosun Pharmaceutical (Group) Recent Development
11.12 WuXi Biologics
11.12.1 WuXi Biologics Company Details
11.12.2 WuXi Biologics Business Overview
11.12.3 WuXi Biologics Monoclonal Antibody Discovery Platform Introduction
11.12.4 WuXi Biologics Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025)
11.12.5 WuXi Biologics Recent Development
11.13 Lepu Biopharma
11.13.1 Lepu Biopharma Company Details
11.13.2 Lepu Biopharma Business Overview
11.13.3 Lepu Biopharma Monoclonal Antibody Discovery Platform Introduction
11.13.4 Lepu Biopharma Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025)
11.13.5 Lepu Biopharma Recent Development
11.14 Harbour BioMed
11.14.1 Harbour BioMed Company Details
11.14.2 Harbour BioMed Business Overview
11.14.3 Harbour BioMed Monoclonal Antibody Discovery Platform Introduction
11.14.4 Harbour BioMed Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025)
11.14.5 Harbour BioMed Recent Development
11.15 3SBio Group
11.15.1 3SBio Group Company Details
11.15.2 3SBio Group Business Overview
11.15.3 3SBio Group Monoclonal Antibody Discovery Platform Introduction
11.15.4 3SBio Group Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025)
11.15.5 3SBio Group Recent Development
11.16 SAFE Pharmaceutical Technology
11.16.1 SAFE Pharmaceutical Technology Company Details
11.16.2 SAFE Pharmaceutical Technology Business Overview
11.16.3 SAFE Pharmaceutical Technology Monoclonal Antibody Discovery Platform Introduction
11.16.4 SAFE Pharmaceutical Technology Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025)
11.16.5 SAFE Pharmaceutical Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Sartorius
BIOCYTOGEN
Abveris
Integral Molecular
Shanghai Fosun Pharmaceutical Group
Wuxi Biologics
Lepu Biopharma
Harbour Biomed
3SBio Group
SAFE Pharmaceutical Technology
Trianni (AbCellera)
GigaGen
AvantBunny
MAB Discovery (BioNTech)
List of Tables
 Table 1. Global Monoclonal Antibody Discovery Platform Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of FACS (Fluorescent Activated Cell Sorting)
 Table 3. Key Players of LCM (Laser-Capture Microdissection)
 Table 4. Key Players of Microengraving
 Table 5. Key Players of Droplet Microfluidics
 Table 6. Key Players of Other
 Table 7. Global Monoclonal Antibody Discovery Platform Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Monoclonal Antibody Discovery Platform Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Monoclonal Antibody Discovery Platform Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Monoclonal Antibody Discovery Platform Market Share by Region (2020-2025)
 Table 11. Global Monoclonal Antibody Discovery Platform Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Monoclonal Antibody Discovery Platform Market Share by Region (2026-2031)
 Table 13. Monoclonal Antibody Discovery Platform Market Trends
 Table 14. Monoclonal Antibody Discovery Platform Market Drivers
 Table 15. Monoclonal Antibody Discovery Platform Market Challenges
 Table 16. Monoclonal Antibody Discovery Platform Market Restraints
 Table 17. Global Monoclonal Antibody Discovery Platform Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Monoclonal Antibody Discovery Platform Market Share by Players (2020-2025)
 Table 19. Global Top Monoclonal Antibody Discovery Platform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Discovery Platform as of 2024)
 Table 20. Ranking of Global Top Monoclonal Antibody Discovery Platform Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Monoclonal Antibody Discovery Platform Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Monoclonal Antibody Discovery Platform, Headquarters and Area Served
 Table 23. Global Key Players of Monoclonal Antibody Discovery Platform, Product and Application
 Table 24. Global Key Players of Monoclonal Antibody Discovery Platform, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Monoclonal Antibody Discovery Platform Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Monoclonal Antibody Discovery Platform Revenue Market Share by Type (2020-2025)
 Table 28. Global Monoclonal Antibody Discovery Platform Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Monoclonal Antibody Discovery Platform Revenue Market Share by Type (2026-2031)
 Table 30. Global Monoclonal Antibody Discovery Platform Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Monoclonal Antibody Discovery Platform Revenue Market Share by Application (2020-2025)
 Table 32. Global Monoclonal Antibody Discovery Platform Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Monoclonal Antibody Discovery Platform Revenue Market Share by Application (2026-2031)
 Table 34. North America Monoclonal Antibody Discovery Platform Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Monoclonal Antibody Discovery Platform Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Monoclonal Antibody Discovery Platform Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Monoclonal Antibody Discovery Platform Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Monoclonal Antibody Discovery Platform Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Monoclonal Antibody Discovery Platform Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Monoclonal Antibody Discovery Platform Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Monoclonal Antibody Discovery Platform Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Monoclonal Antibody Discovery Platform Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Monoclonal Antibody Discovery Platform Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Monoclonal Antibody Discovery Platform Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Monoclonal Antibody Discovery Platform Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Monoclonal Antibody Discovery Platform Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Monoclonal Antibody Discovery Platform Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Monoclonal Antibody Discovery Platform Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Sartorius Company Details
 Table 50. Sartorius Business Overview
 Table 51. Sartorius Monoclonal Antibody Discovery Platform Product
 Table 52. Sartorius Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025) & (US$ Million)
 Table 53. Sartorius Recent Development
 Table 54. Trianni (AbCellera) Company Details
 Table 55. Trianni (AbCellera) Business Overview
 Table 56. Trianni (AbCellera) Monoclonal Antibody Discovery Platform Product
 Table 57. Trianni (AbCellera) Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025) & (US$ Million)
 Table 58. Trianni (AbCellera) Recent Development
 Table 59. Biocytogen Company Details
 Table 60. Biocytogen Business Overview
 Table 61. Biocytogen Monoclonal Antibody Discovery Platform Product
 Table 62. Biocytogen Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025) & (US$ Million)
 Table 63. Biocytogen Recent Development
 Table 64. Abveris Company Details
 Table 65. Abveris Business Overview
 Table 66. Abveris Monoclonal Antibody Discovery Platform Product
 Table 67. Abveris Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025) & (US$ Million)
 Table 68. Abveris Recent Development
 Table 69. Creative Biolabs Company Details
 Table 70. Creative Biolabs Business Overview
 Table 71. Creative Biolabs Monoclonal Antibody Discovery Platform Product
 Table 72. Creative Biolabs Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025) & (US$ Million)
 Table 73. Creative Biolabs Recent Development
 Table 74. Integral Molecular Company Details
 Table 75. Integral Molecular Business Overview
 Table 76. Integral Molecular Monoclonal Antibody Discovery Platform Product
 Table 77. Integral Molecular Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025) & (US$ Million)
 Table 78. Integral Molecular Recent Development
 Table 79. GigaGen Company Details
 Table 80. GigaGen Business Overview
 Table 81. GigaGen Monoclonal Antibody Discovery Platform Product
 Table 82. GigaGen Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025) & (US$ Million)
 Table 83. GigaGen Recent Development
 Table 84. Creative Biolabs Company Details
 Table 85. Creative Biolabs Business Overview
 Table 86. Creative Biolabs Monoclonal Antibody Discovery Platform Product
 Table 87. Creative Biolabs Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025) & (US$ Million)
 Table 88. Creative Biolabs Recent Development
 Table 89. AvantBunny Company Details
 Table 90. AvantBunny Business Overview
 Table 91. AvantBunny Monoclonal Antibody Discovery Platform Product
 Table 92. AvantBunny Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025) & (US$ Million)
 Table 93. AvantBunny Recent Development
 Table 94. MAB Discovery (BioNTech) Company Details
 Table 95. MAB Discovery (BioNTech) Business Overview
 Table 96. MAB Discovery (BioNTech) Monoclonal Antibody Discovery Platform Product
 Table 97. MAB Discovery (BioNTech) Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025) & (US$ Million)
 Table 98. MAB Discovery (BioNTech) Recent Development
 Table 99. Shanghai Fosun Pharmaceutical (Group) Company Details
 Table 100. Shanghai Fosun Pharmaceutical (Group) Business Overview
 Table 101. Shanghai Fosun Pharmaceutical (Group) Monoclonal Antibody Discovery Platform Product
 Table 102. Shanghai Fosun Pharmaceutical (Group) Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025) & (US$ Million)
 Table 103. Shanghai Fosun Pharmaceutical (Group) Recent Development
 Table 104. WuXi Biologics Company Details
 Table 105. WuXi Biologics Business Overview
 Table 106. WuXi Biologics Monoclonal Antibody Discovery Platform Product
 Table 107. WuXi Biologics Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025) & (US$ Million)
 Table 108. WuXi Biologics Recent Development
 Table 109. Lepu Biopharma Company Details
 Table 110. Lepu Biopharma Business Overview
 Table 111. Lepu Biopharma Monoclonal Antibody Discovery Platform Product
 Table 112. Lepu Biopharma Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025) & (US$ Million)
 Table 113. Lepu Biopharma Recent Development
 Table 114. Harbour BioMed Company Details
 Table 115. Harbour BioMed Business Overview
 Table 116. Harbour BioMed Monoclonal Antibody Discovery Platform Product
 Table 117. Harbour BioMed Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025) & (US$ Million)
 Table 118. Harbour BioMed Recent Development
 Table 119. 3SBio Group Company Details
 Table 120. 3SBio Group Business Overview
 Table 121. 3SBio Group Monoclonal Antibody Discovery Platform Product
 Table 122. 3SBio Group Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025) & (US$ Million)
 Table 123. 3SBio Group Recent Development
 Table 124. SAFE Pharmaceutical Technology Company Details
 Table 125. SAFE Pharmaceutical Technology Business Overview
 Table 126. SAFE Pharmaceutical Technology Monoclonal Antibody Discovery Platform Product
 Table 127. SAFE Pharmaceutical Technology Revenue in Monoclonal Antibody Discovery Platform Business (2020-2025) & (US$ Million)
 Table 128. SAFE Pharmaceutical Technology Recent Development
 Table 129. Research Programs/Design for This Report
 Table 130. Key Data Information from Secondary Sources
 Table 131. Key Data Information from Primary Sources
 Table 132. Authors List of This Report


List of Figures
 Figure 1. Monoclonal Antibody Discovery Platform Picture
 Figure 2. Global Monoclonal Antibody Discovery Platform Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Monoclonal Antibody Discovery Platform Market Share by Type: 2024 VS 2031
 Figure 4. FACS (Fluorescent Activated Cell Sorting) Features
 Figure 5. LCM (Laser-Capture Microdissection) Features
 Figure 6. Microengraving Features
 Figure 7. Droplet Microfluidics Features
 Figure 8. Other Features
 Figure 9. Global Monoclonal Antibody Discovery Platform Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Monoclonal Antibody Discovery Platform Market Share by Application: 2024 VS 2031
 Figure 11. Biomedical Research Case Studies
 Figure 12. Disease Diagnosis and Treatment Case Studies
 Figure 13. Other Case Studies
 Figure 14. Monoclonal Antibody Discovery Platform Report Years Considered
 Figure 15. Global Monoclonal Antibody Discovery Platform Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Monoclonal Antibody Discovery Platform Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Monoclonal Antibody Discovery Platform Market Share by Region: 2024 VS 2031
 Figure 18. Global Monoclonal Antibody Discovery Platform Market Share by Players in 2024
 Figure 19. Global Top Monoclonal Antibody Discovery Platform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Discovery Platform as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Monoclonal Antibody Discovery Platform Revenue in 2024
 Figure 21. North America Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Monoclonal Antibody Discovery Platform Market Share by Country (2020-2031)
 Figure 23. United States Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Monoclonal Antibody Discovery Platform Market Share by Country (2020-2031)
 Figure 27. Germany Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Monoclonal Antibody Discovery Platform Market Share by Region (2020-2031)
 Figure 35. China Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Monoclonal Antibody Discovery Platform Market Share by Country (2020-2031)
 Figure 43. Mexico Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Monoclonal Antibody Discovery Platform Market Share by Country (2020-2031)
 Figure 47. Turkey Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Monoclonal Antibody Discovery Platform Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Sartorius Revenue Growth Rate in Monoclonal Antibody Discovery Platform Business (2020-2025)
 Figure 51. Trianni (AbCellera) Revenue Growth Rate in Monoclonal Antibody Discovery Platform Business (2020-2025)
 Figure 52. Biocytogen Revenue Growth Rate in Monoclonal Antibody Discovery Platform Business (2020-2025)
 Figure 53. Abveris Revenue Growth Rate in Monoclonal Antibody Discovery Platform Business (2020-2025)
 Figure 54. Creative Biolabs Revenue Growth Rate in Monoclonal Antibody Discovery Platform Business (2020-2025)
 Figure 55. Integral Molecular Revenue Growth Rate in Monoclonal Antibody Discovery Platform Business (2020-2025)
 Figure 56. GigaGen Revenue Growth Rate in Monoclonal Antibody Discovery Platform Business (2020-2025)
 Figure 57. Creative Biolabs Revenue Growth Rate in Monoclonal Antibody Discovery Platform Business (2020-2025)
 Figure 58. AvantBunny Revenue Growth Rate in Monoclonal Antibody Discovery Platform Business (2020-2025)
 Figure 59. MAB Discovery (BioNTech) Revenue Growth Rate in Monoclonal Antibody Discovery Platform Business (2020-2025)
 Figure 60. Shanghai Fosun Pharmaceutical (Group) Revenue Growth Rate in Monoclonal Antibody Discovery Platform Business (2020-2025)
 Figure 61. WuXi Biologics Revenue Growth Rate in Monoclonal Antibody Discovery Platform Business (2020-2025)
 Figure 62. Lepu Biopharma Revenue Growth Rate in Monoclonal Antibody Discovery Platform Business (2020-2025)
 Figure 63. Harbour BioMed Revenue Growth Rate in Monoclonal Antibody Discovery Platform Business (2020-2025)
 Figure 64. 3SBio Group Revenue Growth Rate in Monoclonal Antibody Discovery Platform Business (2020-2025)
 Figure 65. SAFE Pharmaceutical Technology Revenue Growth Rate in Monoclonal Antibody Discovery Platform Business (2020-2025)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions